|The IGJ jchain (Catalog #MBS8252419) is a shRNA produced from E Coli and is intended for research purposes only. The product is available for immediate purchase. The IGJ shRNA Plasmid (Human) reacts with Human and may cross-react with other species as described in the data sheet. MyBioSource\'s IGJ can be used in a range of immunoassay formats including, but not limited to, RNA interference (RNAi). Researchers should empirically determine the suitability of the IGJ jchain for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.
The IGJ jchain product has the following accession number(s) (GI #21489959) (NCBI Accession #NP_653247.1) (Uniprot Accession #P01591). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
shRNA Plasmid to inhibit IGJ expression by RNA interference.
Quality Control: The sequence of shRNA is guaranteed by sequencing. Directions for Use: Resuspend lyophilized shRNA plasmid DNA in 500 ul of the deionized water. Each vial contains 50 ug of lyophilized shRNA plasmid DNA. Suitable for up to 50 transfections.
Components: We offer 3 different plasmids which knock down human IGJ gene specifically. Each vial contains 50 ug of lyophilized shRNA. Congenital Abnormalities, Drug Toxicity, Edema, Heart Defects, Congenital, Heart Diseases, Immune System Diseases, Liver Diseases, Lymphoma, Necrosis, Neoplasms are some of the diseases may be linked to IGJ shRNA Plasmid (Human). Intestine, Kidney, Lymph Node, Pancreas, Stomach, Uterus tissues are correlated with this protein.